CPT code 0782T describes a bronchoscopic endobronchial radiofrequency ablation procedure in which a catheter is passed through a bronchoscope to perform circumferential ablation of pulmonary nerves in the main bronchus of one lung. The code captures a targeted, therapeutic airway intervention intended to disrupt autonomic innervation of the bronchus.

This code matters nationally as an example of emerging, image-guided bronchoscopic therapies that raise clinical, coding, and coverage considerations for payers and providers. Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. These payers are referenced to illustrate typical coverage language, prior authorization patterns, and reimbursement approaches for advanced bronchoscopic procedures.

Readers will learn: a concise clinical description and service setting for the code; which major payers appear in payer policy discussions; common billing and administrative considerations related to endobronchial radiofrequency services; and where to find relevant documentation and coding guidance. Data not available in the input is noted where applicable. This summary provides a national, payer-agnostic overview intended to inform coding, clinical documentation, and revenue-cycle stakeholders about the core definition and policy context for CPT code 0782T.